Table of Content

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for this Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Chronic Diseases Coupled with the Increasing Geriatric Population
4.2.2. Growing Prevalence of Infectious Diseases
4.2.3. Increasing Need for Rapid Decision-making & Growing Demand for Point-of-Care (POC) Diagnostics
4.2.4. The Outbreak of the COVID-19 Pandemic
4.3. Restraints
4.3.1. Variance in Test Results
4.4. Opportunities
4.4.1. Untapped Potential in Emerging Economies of the Countries in the Indian Ocean Region
4.5. Challenges
4.5.1. Reluctance toward Changing Existing Diagnostic Practices
4.6. Rapid Diagnostics: Innovations & Upcoming Technologies

5. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Product
5.1. Introduction
5.2. Professional Kits
5.3. OTC Kits

6. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Platform
6.1. Introduction
6.2. Immunoassays
6.3. Molecular Detection Tests
6.4. Other Rapid Diagnostic Platforms

7. Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by Application
7.1. Introduction
7.2. Infectious Diseases Testing
7.3. Pregnancy & Fertility Testing
7.4. Cardiac Metabolism Testing
7.5. Cholesterol Testing
7.6. Tumor/Cancer Markers Testing
7.7. Blood Glucose Testing
7.8. Urinalysis
7.9. Hematology Testing
7.10. Other Tests

8. Rapid Diagnostic Kits Market for Indian Ocean Region Countries, by End User
8.1. Introduction
8.2. Hospital & Clinics
8.3. Diagnostic Laboratories
8.4. Home Care/Self-testing
8.5. Other End Users

9. Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Geography
9.1. Introduction
9.2. France
9.3. India
9.4. Australia
9.5. Indonesia
9.6. Singapore
9.7. Sri Lanka
9.8. Madagascar
9.9. Mauritius
9.10. R?union
9.11. Mayotte
9.12. Seychelles
9.13. Comoros

10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
11.1. Abbott Laboratories (U.S.)
11.2. Becton, Dickinson and Company (BD) (U.S.)
11.3. Bio-Rad Laboratories, Inc. (U.S.)
11.4. F. Hoffmann-La Roche Ltd (Switzerland)
11.5. ACON Laboratories, Inc. (U.S.)
11.6. Danaher Corporation (U.S.)
11.7. Thermo Fisher Scientific Inc. (U.S.)
11.8. bioM?rieux S.A. (France)
11.9. Alfa Scientific Designs, Inc. (U.S.)
11.10. BTNX Inc. (Canada)
11.11. Meridian Bioscience, Inc. (U.S.)
11.12. Trinity Biotech plc (Ireland)

12. Appendix
12.1. Questionnaire



List of Figures

List of Figures

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 8 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 9 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Application, 2022 VS. 2029 (USD Million)
Figure 10 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022 VS. 2029 (USD Million)
Figure 11 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by Country, 2022 VS. 2029
Figure 12 Market Dynamics
Figure 13 Rapid Diagnostic Kits Market in Indian Ocean Region Countries, by Product, 2022 VS. 2029 (USD Million)
Figure 14 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Platform, 2022 VS. 2029 (USD Million)
Figure 15 Rapid Diagnostic Kits Market for Indian Ocean Region Countries Size, by Application, 2022 VS. 2029 (USD Million)
Figure 16 Deaths Due to Heart Attacks in India (2017–2020)
Figure 17 Estimated Number of New Cancer Cases in Some of the Countries of the Indian Ocean Region, 2020–2030
Figure 18 Prevalence of Impaired Glucose Tolerance in India & Indonesia (2019–2045) (Million)
Figure 19 Estimated Number of New Leukemia Cases in Some of the Countries in the Indian Ocean Region (2020–2030)
Figure 20 Estimated Number of New Colon Cancer Cases in Some of the Indian Ocean Region Countries (2020 VS. 2030)
Figure 21 Rapid Diagnostic Kits Market Size for Indian Ocean Region Countries, by End User, 2022–2029 (USD Million)
Figure 22 Healthcare Expenditure Per Capita, Purchasing Power Parities (PPP), (USD), 2019
Figure 23 Rapid Diagnostic Kits Market Size in Indian Ocean Region Countries, by Country, 2022–2029 (USD Million)
Figure 24 France: Percentage of Population Aged 65 Years and Above, 2016–2020
Figure 25 France: Prevalence of Chronic Diseases in People Aged 65 and Above (2019)
Figure 26 France: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 27 India: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 28 Australia: Most Prevalent Chronic Diseases (2020–2021) (% of Total Population)
Figure 29 Australia: Infectious Disease Cases, in Thousand (2017–2021)
Figure 30 Australia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 31 Indonesia: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 32 Singapore: Number of Deaths Due to Diseases (% of Total Population) (2019–2020)
Figure 33 Singapore: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 34 Sri Lanka: Government Health Expenditure (2017–2019)
Figure 35 Sri Lanka: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 36 Madagascar: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 37 Mauritius: Deaths Per 100,000 People Due to Ncd (2017–2020)
Figure 38 Mauritius: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 39 R?union: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 40 Mayoytte: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 41 Seychelles: Number of People Aged 65 Years and Above
Figure 42 Seychelles: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 43 Comoros: Number of People Aged 65 Years and Above (2015–2021)
Figure 44 Comoros: Rapid Diagnostic Kits Market Size, 2020–2029 (USD Million)
Figure 45 Key Growth Strategies Adopted by Leading Players (2019–2022)
Figure 46 Rapid Diagnostic Kits Market for Indian Ocean Region Countries: Competitive Benchmarking, by Platform
Figure 47 Abbott Laboratories: Financial Overview (2021)
Figure 48 Becton, Dickinson and Company: Financial Overview (2021)
Figure 49 Bio-Rad Laboratories, Inc.: Financial Overview (2021)
Figure 50 F. Hoffmann-La Roche Ltd: Financial Overview (2021)
Figure 51 Danaher Corporation: Financial Overview (2021)
Figure 52 Thermo Fisher Scientific Inc.: Financial Overview (2021)
Figure 53 bioM?rieux S.A.: Financial Overview (2021)
Figure 54 Meridian Bioscience, Inc.: Financial Overview (2021)
Figure 55 Trinity Biotech plc: Financial Overview (2021)